Real-life efficacy and safety of biologic treatment in patients with moderate to severe psoriasis and previous diagnosis of a malignant tumor: Single-center descriptive study

被引：0
|
作者：
Duran Romero, Antonio Jose [1 ]
Fernandez Freire, Lourdes Rodriguez [1 ]
Sendin Martin, Mercedes [1 ]
Ortiz Alvarez, Juan [1 ]
Hernandez Rodriguez, Juan Carlos [1 ]
Conejo-Mir Sanchez, Julian [1 ]
机构：
[1] Univ Hosp Virgen Rocio, Dermatol Dept, Seville, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34115
引用
收藏
页码：AB198 / AB198
页数：1
相关论文
共 50 条
  • [21] Real-life effectiveness and safety of vedolizumab in moderate-to-severe ulcerative colitis A single-center experience in Northern China
    Yan, Jing
    Ding, Xueli
    Wu, Jun
    Liu, Ailing
    Fang, Liang
    Xu, Yonghong
    MEDICINE, 2024, 103 (27) : e38759
  • [22] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun Yuankai
    Wang Jiajia
    Qiu Yulu
    Lin Shiyu
    Wang Fang
    Tan Wenfeng
    中华医学杂志英文版, 2022, 135 (21)
  • [23] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun, Yuankai
    Wang, Jiajia
    Qiu, Yulu
    Lin, Shiyu
    Wang, Fang
    Tan, Wenfeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2623 - 2624
  • [24] "Real-life" outcome of gastrointestinal tumor therapies: A single-center comparative study
    Buratti, Thomas
    Mair, Maximilian
    Muehlberger, Nikolai
    Mitterer, Manfred
    CANCER REPORTS, 2019, 2 (05)
  • [25] Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
    Gargiulo, Luigi
    Ibba, Luciano
    Cortese, Andrea
    Avagliano, Jessica
    Valenti, Mario
    Costanzo, Antonio
    Narcisi, Alessandra
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 651 - 660
  • [26] Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
    Luigi Gargiulo
    Luciano Ibba
    Andrea Cortese
    Jessica Avagliano
    Mario Valenti
    Antonio Costanzo
    Alessandra Narcisi
    Dermatology and Therapy, 2023, 13 : 651 - 660
  • [27] Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study
    Thaci, D.
    Koerber, A.
    von Kiedrowski, R.
    Bachhuber, T.
    Melzer, N.
    Kasparek, T.
    Duetting, E.
    Kraehn-Senftleben, G.
    Amon, U.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (02) : 310 - 318
  • [28] Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series
    Megna, Matteo
    Fabbrocini, Gabriella
    Gallo, Lucia
    Ruggiero, Angelo
    Camela, Elisa
    Ocampo-Garza, Sonia Sofia
    Cinelli, Eleonora
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (06) : 819 - 822
  • [29] Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
    Gnesotto, Laura
    Mioso, Guido
    Bardazzi, Federico
    Filippi, Federica
    Di Lernia, Vito
    Motolese, Alberto
    Di Nuzzo, Sergio
    Conti, Andrea
    Arginelli, Federica
    Corazza, Monica
    Odorici, Giulia
    Borghi, Alessandro
    Gisondi, Paolo
    Naldi, Luigi
    Dapavo, Paolo
    Parodi, Aurora
    Burlando, Martina
    Piaserico, Stefano
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [30] Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
    Megna, Matteo
    Potestio, Luca
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    PSORIASIS-TARGETS AND THERAPY, 2022, 12 : 205 - 212
12345